- ►diabetesjournals.org [PDF] B Isomaa, P Almgren, M Henricsson, MR Taskinen, … - Diabetes Care, 1999 - Am Diabetes Assoc F rom Jakobstad Hospital (BI, LS), Jakobstad; the Department of Medicine (M.-RT), Helsinki University
Hospital, Helsinki, Finland; Helsingborg Hospital (MH), Helsingbord; and the Department of
Endocrinol- ogy (TT, PA, LG), Lund University, Malmö, Sweden. A dd ress ... Cited by 61 - Related articles - BL Direct - All 7 versions
- ►endojournals.org AL Carlsson, G Sundkvist, L Groop, T Tuomi - Journal of Clinical …, 2000 - Endocrine Soc To metabolically characterize patients with slowly progressing autoimmune diabetes (LADA)
of short duration we measured insulin, C peptide, and glucagon responses to glucose and arginine
at three blood glucose levels (fasting and 14 and 28 mmol/L) in 11 patients with LADA, 11 ... Cited by 84 - Related articles - BL Direct - All 5 versions
A Maruyama, A Shimada, A KANATSUKA, A … - Ann. NY Acad. …, 2003 - interscience.wiley.com Abstract: In 1996, we designed a randomized multicenter study to assess the effects of small
doses of insulin on beta cell failure in slowly progressive type 1 diabetes (the Tokyo Study). We
report here the preliminary results of this study. Glutamic acid decarboxylase 65 antibody ( ... Cited by 39 - Related articles - BL Direct - All 5 versions
LK Niskanen, T Tuomi, J Karjalainen, LC Groop, MI … - Diabetes Care, 1995 - Am Diabetes Assoc OBJECTIVE: To study the frequency of antibodies to glutamic acid decarboxylase (GAD) and
islet cell antibodies (ICAs) and their predictive value with respect to the development of insulin
deficiency in 133 newly diagnosed middle-aged patients with non-insulin-dependent ... Cited by 96 - Related articles - BL Direct - All 6 versions
G Gambelunghe, F Forini, S Laureti, G … - Clinical …, 2000 - interscience.wiley.com We analysed serum samples from 600 adult subjects with a clinical diagnosis of type 2 diabetes
mellitus for the presence and levels of GAD65Ab and antibodies directed against the islet autoantigen
IA-2/ICA512 (IA-2/ICA512Ab). All the patients had been treated initially with ... Cited by 74 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org [PDF] T Tuomi, A Carlsson, H Li, B Isomaa, A Miettinen, A … - Diabetes, 1999 - Am Diabetes Assoc The aim of the study was 1) to establish the prevalence of GAD antibodies (GADab) in a
population-based study of type 2 diabetes in western Finland, 2) to genet- ically and phenotypically
characterize this subgroup, and 3) to provide a definition for latent autoimmune dia- betes ... Cited by 304 - Related articles - BL Direct - All 5 versions
M Balme, I McAllister, WA Davis, TME Davis - Diabetic Medicine, 2002 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 10 - Related articles - BL Direct - All 4 versions
PE Beales, A Giorgini, A Annovazzi, A … - Hormone and …, 1997 - thieme-connect.com In insulin-dependent (type 1) diabetes mellitus, increasing peripheral insulin sensitivity might
be a useful approach in controlling the process leading to beta cell destruction by reducing insulin
output and thereby reducing the antigenicity associated with its release. The aim of this ... Cited by 11 - Related articles - BL Direct - All 3 versions
H Takeda, E Kawasaki, I Shimizu, E Konoue, M … - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—GADab was detected in 188 (3.8%) of the 4,980 diabetic patients tested. Of these
patients, 72 (38.3%) were classified as insulin deficient, 97 (51.6%) were classified as non–insulin
deficient, and 19 (10.1%) were unclassified. The GADab + insulin-deficient patients were ... Cited by 38 - Related articles - BL Direct - All 5 versions
